ImageVerifierCode 换一换
格式:PPT , 页数:55 ,大小:11.92MB ,
资源ID:3387744      下载积分:20 金币
快捷下载
登录下载
邮箱/手机:
温馨提示:
快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。 如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.docduoduo.com/d-3387744.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录   QQ登录   微博登录 

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(房颤治疗策略课件.ppt)为本站会员(微传9988)主动上传,道客多多仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知道客多多(发送邮件至docduoduo@163.com或直接QQ联系客服),我们立即给予删除!

房颤治疗策略课件.ppt

1、Treating Atrial Fibrillation Richard Schilling,St Bartholomews Hospital, Queen Marys University of London,AF burden,Framingham Lifetime risk of developing AF = 25% Mortality: SMR =1.9 1.5 NHS audit 1% of budget spent on AF - 688, 000, 000 in 2000 Quality of life Symptoms of AF Side effects of medica

2、tion,Benjamin, E. J. et al. “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.“ Circulation 98.10 (1998): 946-52. Stewart, S. et al. “Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.“ Heart 90.3 (2004): 286-92,ATRIAL FIBRILLATION Inci

3、dence,Framingham Heart Study,Nice guidance for management of AF,Issued on June 2006 Aimed to give a UK based simple guidance on management of AF Attempts to be evidence based And applicable to the majority of patients,Key aims of management,Diagnosis - everyone with irregular pulse gets ECG Identify

4、 secondary causes (thyroid, hypertension, valve disease) Treatment Stroke prevention Rate control Rhythm control where appropriate,Diagnosis,AF can only be diagnosed on an ECG recorded during symptoms/signs Even asymptomatic patients should have an ECG Consider 24 hour to 7 day Holter if intermitten

5、t (depending on frequency) Or ask patient to attend A+E during symptoms and get a copy of ECG,Investigation,TFT Echo If young If rhythm control strategy If unsure of stroke risk If structural heart disease suspected,Stroke prevention,Warfarin (INR 2-3),Aspirin,Rate control vs rhythm control,RACE Mor

6、tality 22.6% vs 17.2% 39% vs 10% in SR AFFIRM Mortality 23.8% vs 21.3 % hospitalisation Side effects SR has a prognostic benefit,Rhythm control - problem,Cardioversion and drugs maintains SR in 42% at one year (amiodarone) Side effects require stopping amiodarone in 25% Anticoagulation stopped too e

7、arly,Treatment decision tree,Advantages of Warfarin over Aspirin,Advantages of Warfarin over Aspirin,rhythm vs rate control,Persistent AF rate control,Specialist referral,Rhythm control,Rate control vs Rhythm control,AF is dangerous SR is better and confers mortality benefit Conventional therapies a

8、re poor at maintaining SR The population is aging,What specialist treatments are available?,Antiarrhythmic drugs Pacemaker Catheter ablation Surgical ablation,AV node ablation and pacing,AV node ablation and pacing,“hides” the AF Easy to perform (99%) success No atrial transport (turbo) Pacing depen

9、dent (LBBB) No going back Refuge of the elderly and desperate,The first curative procedure Maze JL Cox et al 1991,Why does the maze work?,Radiofrequency Ablation Catheter,Lesion cross-section,How is RF energy applied,RFA Lesion - Macroscopic,Atrial fibrillation originates in the left atrium,Mechanis

10、ms for AF,Target PV trigger,LIMITED BY: Absence of spontaneous ectopy Multiple triggers,Focal AF: RFA to “disconnect” PV potential,Continuous circular lesions,Catheter ablation in permanent AF,Earley et al. Heart 2005,MV,31/41(76%) in SR at 8.4 mths,The electroanatomical approach,The anatomy is very

11、 stylised Accurate lesion location is very dependent on experience,CT integration,True 3-dimensional anatomy with catheter localisation,Creating 3 landmark pairs,LPV locations of interest,LPV internal view,Does this have a clinical effect?,LUPV,LAA,LLPV,Ablation lines,Isolation of LPVs during AF,Pra

12、cticalities of curative AF ablation,Pre op - CT few weeks pre-op TOE on day ACT 300 during procedure Procedure time 2-3 hours PAF/ 3-4 hours Persistent Post-op echo Warfarin loading on night of procedure Continues for 3 months if low risk Enoxaparin day after until INR2,Case Control Study of 3-D map

13、ping vs CT integration,105 patients 6 month follow up 7 day holter at 3 months Similar operator profile and experience,AF ablation results,Freedom from AT/AF off medication at 6 month follow up,CT integration (n = 53),3D mapping (n = 52),P value,Complications of AF ablation,2% pericardial effusion/t

14、amponade 3% Femoral haematoma 0.5% stroke/TIA 0.5% PV stenosis,Recurrence,Usually occurs 3months (late recurrence is rare) May settle over a 3 to 6 month period Results in 28% to 40% of patients requiring redo,How does ablation compare to drugs?,Ablation vs drugs,Does ablation improve prognosis?,Pap

15、pone et al circulation 2001,Complications of AF ablation,AF ablation is good for your garden,AF ablation for heart failure,Patients with EF45% and AF Randomised to medical therapy or med therapy and catheter ablation 21 patients enrolled so far 15 patients with at least 1 month FU 7 Catheter Ablatio

16、n 8 Medical,Preliminary results,2 pts recurrence after ablation awaiting redo 6pts improved 1 NYHA 5% EF after 1 month,Who should have AF ablation,Symptomatic (incl heart failure?) Persistent AF for 5 years Prepared to go through multiple procedures Prepared for the risks,Limitations of AF ablation,

17、High volume does make a difference Redos are common Tarrif does not reflect cost Serious complications are increasingly rare but do occur Team work is critical,Conclusion,AF is common Priorities for treatment now clearly defined Cure is now possible but at a cost The “lost tribe” of AF sufferers now have hope The epidemic may have a solution ,

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:道客多多官方知乎号:道客多多

经营许可证编号: 粤ICP备2021046453号世界地图

道客多多©版权所有2020-2025营业执照举报